Non-linear effects of age in reporting of adverse events following influenza immunization in Zhejiang, China

被引:0
|
作者
Chen, Fuxing [1 ]
Chen, Yaping [1 ]
Liang, Hui [1 ]
Pan, Xuejiao [1 ]
Wang, Ying [1 ]
Shen, Lingzhi [1 ]
Hu, Yu [1 ]
机构
[1] Zhejiang Ctr Dis Control & Prevent, Inst Immunizat & Prevent, 3399 Binsheng Rd, Hangzhou, Peoples R China
关键词
Age; Non-linear effects; Influenza vaccine; Interactions; Adverse events following immunization; SEX; SURVEILLANCE; VACCINATION; SAFETY;
D O I
10.1186/s12879-024-10385-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Previous evidence had suggested age and sex affect the reporting rate of adverse events following immunization (AEFI), but with little exploration of potential their non-linear and interaction effects on AEFIs. Examining these non-linear effects could be beneficial for identifying high-risk populations. Methods Using AEFI records and vaccination data from national passive surveillance system of adverse event following immunization and Zhejiang provincial immunization information system in the 2021-2022 influenza season, respectively. The effects of age and sex on AEFIs were analyzed through the generalized additive model (logistic regression with a smooth term) to estimate non-linear characteristics after adjusting for other co-variables (adopted significance level p < 0.05). Results There were 1,259,975 influenza vaccine doses administered and 1304 AEFI records reported during the 2021-2022 influenza season, with a reporting rate of 10.35/10,000 doses. The odds of reporting an AEFI increased from 6 months of age, peaking at about 54 years of age, then gradually declined. The odds of females experiencing AEFIs are higher than that of males. The data model indicated clear effects of age, sex, and their interaction (p < 0.01) on reporting rate of AEFI. Concomitant vaccination and vaccine type were also the impact factors for reporting rate of AEFI. Conclusion This study revealed a non-linear property in age and the AEFI odds, with a significant interaction and higher reporting rate in females. In addition, the odds of AEFI increased with co-administration compared to separate vaccination.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China
    Lv, Huakun
    Pan, Xuejiao
    Wang, Ying
    Liang, Hui
    Yu, Hu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [2] Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
    Pan, Xuejiao
    Lv, Huakun
    Liang, Hui
    Wang, Ying
    Shen, Linzhi
    Chen, Fuxing
    Chen, Yaping
    Hu, Yu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [3] Surveillance of psychogenic adverse events following immunization in Zhejiang, China, 2020–2023
    Xuejiao Pan
    Xiaohua Qi
    Yaping Chen
    Hui Liang
    BMC Public Health, 25 (1)
  • [4] Consumer reporting of adverse events following immunization
    Clothier, Hazel J.
    Selvaraj, Gowri
    Easton, Mee Lee
    Lewis, Georgina
    Crawford, Nigel W.
    Buttery, Jim P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (12) : 3726 - 3730
  • [5] Reporting of adverse events following immunization in Australia
    Isaacs, D
    Lawrence, G
    Boyd, I
    Ronaldson, K
    McEwen, J
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2005, 41 (04) : 163 - 166
  • [6] Surveillance for Adverse Events following Immunization from 2008 to 2011 in Zhejiang Province, China
    Hu, Yu
    Li, Qian
    Lin, Luoya
    Chen, Enfu
    Chen, Yaping
    Qi, Xiaohua
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (02) : 211 - 217
  • [7] Adverse events following influenza immunization: understanding the role of age and sex interactions
    Bohn-Goldbaum, Erika
    Cross, Troy
    Leeb, Alan
    Peters, Ian
    Booy, Robert
    Edwards, Kate M.
    EXPERT REVIEW OF VACCINES, 2022, 21 (03) : 415 - 422
  • [8] Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
    Liang, Hui
    Qi, Xiaohua
    Chen, Yaping
    Pan, Xuejiao
    VACCINES, 2025, 13 (01)
  • [9] Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
    Lv, Huakun
    Pan, Xuejiao
    Liang, Hui
    Wang, Ying
    Hu, Yu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (11) : 4617 - 4622
  • [10] Consumer reporting of adverse events following immunization (AEFI) Identifying predictors of reporting an AEFI
    Parrella, Adriana
    Gold, Michael
    Braunack-Mayer, Annette
    Baghurst, Peter
    Marshall, Helen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (03) : 747 - 754